Roche Middle East

Roche Middle East is the regional division of Roche, a leading global biotechnology company founded in 1896 in Basel, Switzerland. Operating in 16 countries across the Middle East, Roche Middle East serves as a hub for the company's pharmaceutical and diagnostic operations, ensuring alignment with global standards while enhancing local decision-making. Roche focuses on three main areas: Pharmaceuticals & Oncology, In-Vitro Diagnostics (IVD), and Digital Health Solutions. The company has a strong history in cancer research and treatment, providing medicines for various types of cancer and other health conditions. As a leader in in-vitro diagnostics, Roche offers reliable tests that support healthcare providers in delivering timely diagnostic information. Additionally, Roche develops digital health solutions to further improve health outcomes. Roche invests significantly in research and development, committing around 9 billion Swiss francs annually. The company is dedicated to preventing, diagnosing, and curing diseases while emphasizing environmental protection and social responsibility. In December 2022, Roche Diagnostics Middle East achieved ISO 27001 Information Security certification, highlighting its commitment to patient data protection.